01134.HK
Kelfred Holdings Limited
HKSE · Healthcare · Medical - Instruments & Supplies · HK
HKD 0.23
−2.17%Year over year
Reported trailing growth
- Revenue
- +21.1%
- EBITDA
- -17.2%
- EBIT
- —
- EPS
- —
- Free cash flow
- +1618.2%
- Operating cash flow
- +45.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +2.4%
- EBITDA
- -61.2%
- EBIT
- +43.0%
- Net income
- +30.1%
- EPS
- +30.3%
- Free cash flow
- +16.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026